Skip to main content
35°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moleculin Biotech CS
(NQ:
MBRX
)
4.300
UNCHANGED
Streaming Delayed Price
Updated: 3:53 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
4.300
Bid (Size)
3.710 (5)
Ask (Size)
6.590 (4)
Prev. Close
4.300
Today's Range
4.300 - 4.300
52wk Range
0.3377 - 6.240
Shares Outstanding
29,810,443
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Monday's After-Market Session
April 08, 2024
Via
Benzinga
MBRX Stock Earnings: Moleculin Biotech Reported Results for Q4 2023
March 22, 2024
Moleculin Biotech just reported results for the fourth quarter of 2023.
Via
InvestorPlace
Performance
YTD
+365.32%
+365.32%
1 Month
-18.10%
-18.10%
3 Month
+756.06%
+756.06%
6 Month
+725.34%
+725.34%
1 Year
+473.33%
+473.33%
More News
Read More
Earnings Scheduled For March 22, 2024
March 22, 2024
Via
Benzinga
A Preview Of Moleculin Biotech's Earnings
March 21, 2024
Via
Benzinga
Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
Moleculin Biotech's Earnings: A Preview
November 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 24, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 30, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 28, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 22, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 21, 2023
Via
Benzinga
Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
November 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 24, 2023
Via
InvestorPlace
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 20, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 19, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 18, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 10, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.